Introduction: Lung carcinogenesis is strongly influenced by environmental and heritable factors. The genetic contribution to the different histologic subtypes is unknown.
Introduction
Lung cancer is a relatively heterogeneous disease that is classified into NSCLCs and SCLCs. Although it is widely accepted that most subtypes of lung cancer cases are due to cigarette smoking and other behavioral and environmental risk factors, it is well recognized that there are also heritable risks. [1] [2] [3] [4] We have previously presented evidence for the interaction of environmental and genetic contributions in non-smoking-related lung cancers. 5 Here, we further explore the contribution of genes and environment by histologic subtype.
Previous studies have evaluated the relationship between the different histologic subtypes of lung cancer and family history. 6, 7 Others have tried to control for smoking as part of the analysis. 8, 9 The results have been mixed, and the largest limitation is an inability to go beyond first-degree relatives.
The unique Utah Population Database (UPDB) links Utah Cancer Registry (UCR) data from 1966 with genealogy data representing the state of Utah from the mid1800s, and with Utah death certificate (DC) data from 1904 . This allowed us to analyze and examine evidence for a significant genetic contribution to all cancer types [10] [11] [12] [13] and analyze the genetic contribution to many other phenotypes identified in DC data. [14] [15] [16] [17] [18] [19] [20] Here we have analyzed evidence for a significant genetic contribution to lung cancer with consideration for various histologic subtypes of lung cancer, further stratifying cases as smoking related and non-smokingrelated.
Data and Methods

UPDB
Originally created in the 1970s with the use of genealogy data and since expanded by using Utah vital statistics data, the UPDB includes a computerized genealogy of the Utah founders and their descendants. 21 The original genealogy included 1.6 million individuals and extended to six generations. The current UPDB includes more than 7 million unique individuals, with some pedigrees extending to 16 generations. A smaller set of 1.3 million individuals in the UPDB has genealogy data for at least 12 of their 14 immediate ancestors (both parents, all four grandparents, and at least six of their eight great grandparents) and connects to the original Utah genealogy. Individuals meeting these strict criteria were considered to have good genealogy content and were used for the genetic analyses to ensure that the individuals analyzed had similar data available for relatives.
All such individuals in the UPDB were assigned to cohorts based on 5-year birth period, sex, and place of birth (Utah or not). This allowed selection of matched controls for cases and estimation of cohort specific rates of lung cancer by histologic subtype and tobacco use status. Genealogy data in the UPDB is record-linked to various current databases, including the UCR and the computerized Utah DCs.
UCR
The UCR was a founding member of the National Cancer Institute's Surveillance, Epidemiology, and End Results program in 1973, and it has continuously collected data on every cancer diagnosed or treated in Utah since 1966. As of this analysis, the UCR includes 94,822 cancer records for individuals whose cancer was diagnosed up to 2012 and who also have good genealogy content, as described previously. Only independent primary cancers are recorded in the UCR; cancers include all in situ (except in situ cervical cancers) or malignant neoplasms (excluding basal and squamous cell carcinomas of the skin except in genital sites); greater than 98% follow-up is achieved.
Lung cancer cases were identified in the UCR on the basis of primary site coding of the International Classification of Diseases for Oncology codes C340 to C349 (the codes for bronchus and lung), including histologic codes 8000 to 9589 (which excludes leukemias and lymphomas) in the UCR (Table 1) . Lung cancer is a relatively heterogeneous disease that is classified into NSCLC, SCLC, and the less common carcinoid lung cancers. Within the classification for NSCLC, there are multiple histologic subtypes, including squamous, adenocarcinoma, large cell, and other less common subtypes. On the basis of contemporary classifications, NSCLCs were grouped as squamous or nonsquamous. The nonsquamous group consisted of both adenocarcinoma and large cell subtypes. The histologic codes for carcinoid and those that did not permit stratification into the specific subtype of NSCLC or SCLC, or the specific subgroups of squamous and nonsquamous, were excluded.
Utah DCs-Smoking Status
The only available data for smoking status were from Utah DCs. All DCs going back to 1904 have been computerized and record-linked to the UPDB; there are 270,818 Utah DCs in the UPDB for individuals with ancestral genealogy content as previously described. Deaths from 1904 to 1956 were coded to the International Classification of Disease, 10th Revision; other deaths are coded to the sixth to 10th revisions of the International Classification of Disease, according to the year of death. All Utah DCs include primary cause of death, and many include contributing causes of death.
Utah DCs have included data for the contribution of tobacco use to death since 1989. There are six separate distinctions for the contribution of tobacco to death. The category nonuser was used to identify nonsmokers. Two categories, namely, was the underlying cause of death and probably contributed to the cause of death, were used to identify smokers. The categories did not 
GIF Test for Excess Relatedness
The Genealogical Index of Familiality (GIF) test for excess relatedness was designed specifically for use with Utah genealogy and uses an average relatedness measure (GIF statistic) to compare the average relatedness of a group of individuals to the average relatedness expected for a similar group of individuals in the Utah population. This is done by comparing the pairwise relatedness of all pairs of individuals in a set (e.g., all individuals with NSCLC) with their expected pairwise relatedness in the Utah population, as estimated in 1000 sets of matched controls from the UPDB. 13 The pairwise relatedness for a pair is measured as the Malécot coefficient of kinship, which measures the probability that randomly selected homologous genes from a common ancestor are shared identically by descent. 22 The coefficient is related to the genetic distance between the pairs through all common ancestors. Unrelated individuals have a coefficient of 0. The GIF is multiplied by 10 5 for ease of presentation. The significance of the GIF test is measured by selecting 1000 sets of matched (by 5-year birth period, sex, and birth state [Utah or other]) controls from the UPDB and calculating 1000 GIF statistics for these sets. The average pairwise relatedness for the cases is compared with the distribution of the 1000 control GIFs to ascertain the empirical significance of the GIF test. Matched controls for each lung cancer case were selected from all individuals in the UPDB with genealogy content. For smoking and nonsmoking subgroup analyses, which require that cases have linked DCs, matched controls were chosen from individuals with a linked Utah DC. To consider more detail in the observed pairwise relatedness for cases compared with controls we have shown the contribution to the GIF statistic by the pairwise genetic distance. A genetic distance of 1 was used for a parent/offspring; 2 was used for siblings or a grandparent/grandchild; and for example, 3 was used for avunculars, 4 was used for first cousins, 6 was used for second cousins, and so forth (see the example in Fig. 1) .
The overall GIF test performs a test of the hypothesis of no excess familial clustering; the test considers all pairwise relationships. A disease with a strong environmental factor and no genetic contribution might still show excess familial clustering as a result of shared environment and behavior, but this excess would be exhibited in close relationships. For this reason we also considered the distant GIF (dGIF) test, which is similar to the overall GIF test but ignores all pairwise relationships closer than first cousins (genetic distance <4) in cases and controls. A significant dGIF test provides evidence of excess distant relationships, as well as strong support for a heritable contribution to the phenotype tested.
High-risk Pedigrees
By identifying all ancestors of each case, we were able to identify all clusters of related cases descending from a common ancestor (pedigrees). We did not consider clusters/pedigrees that were complete subsets of another, but some individuals may have belonged to more than one cluster from different ancestral lines. To identify which clusters/pedigrees were at high risk for a phenotype of interest, we compared the observed and expected numbers of descendants of the pedigree founder with the phenotype of interest by using the rate of the phenotype calculated internally in the UPDB, as follows.
All individuals in the UPDB with genealogy data as previously described were assigned membership in one of 132 (5-year) birth period-, sex-, and birth state (Utah or not)-specific cohorts. The cohort-specific rate of the phenotype was estimated as the total number of individuals with the phenotype in the cohort divided by the total number of individuals in the cohort. The expected number of affected descendants was estimated by counting all descendants by cohort, multiplying the number of descendants (per cohort) by the cohortspecific rate of the phenotype, and summing over all cohorts. The observed number of affected descendants was counted. The equation Relative risk (RR) ¼ Observed cases/Expected cases was used as an unbiased estimator of RR. One-sided probabilities for the alternative hypothesis test of RR greater than 1.0 were calculated under the null hypothesis that RR would equal 1.0, under the assumption that the number of observed cases would follow a Poisson distribution (an approximation to a sum of multiple binomial distributions representing the number of expected cases per cohort) with the mean equal to the expected number of cases. This Poisson approximation is statistically appropriate for both rare and common phenotypes, being more conservative for a common disease. Each cluster/ pedigree of related cases was tested to identify those exhibiting an excess of affected descendants on the basis of UPDB rates (p < 0.05); these were termed high-risk pedigrees.
Results
There were 5408 individuals with lung/bronchus cancer in the UCR with at least 12 of their 14 immediate ancestors in the genealogy, including those with and without linked DC data. Approximately one-half of those who died of lung cancer had an informative code for tobacco use on their DC, allowing classification of these deceased individuals as smokers or nonsmokers. Table 2 shows the case counts by histologic subtype, the number of individuals who have tobacco use coded on their DC (excluding those considered unknown), and the number and percentage of smokers. The histologic subgroup with the highest rate of death coded as having tobacco use as a contributing factor was SCLC (88%). By comparison, 66% of NSCLC deaths were coded as being due to tobacco use. With regard to lung cancer deaths in the nonesmall cell histologic subgroup, deaths due to nonsquamous cancer had the lowest rate of death coded as being due to tobacco use (59%); in comparison, the rate for squamous cell carcinoma was 82%.
Test for Excess Relatedness (not Controlled for Smoking)
The results for the GIF tests for excess relatedness for the different lung cancer histologic subtypes are shown in Table 3 . These results include all lung cancer cases recorded in the UCR, not just those with DC data available. When all lung cancer cases were considered together, significant overall excess clustering was evident (p < 0.001). Figure 1 shows the contribution to the GIF statistic of cases compared with that of controls by pairwise genetic distance. As seen in Figure 1 , much of the excess relatedness was observed for genetic distances of 1 (parent/offspring) and 2 (primarily siblings), which are relationships with both a shared environment and shared genetics. However, an excess of case relationships over control relationships was still observed out to at least a genetic distance of 7 (second cousins
Each of the histologic subgroups of lung cancer included in Table 3 showed significant overall excess relatedness when all relationships were considered, suggesting excess familial clustering that could be either environmental or genetic, or a combination of both. When close relationships were ignored, there was evidence for excess relatedness in all subgroups except SCLCs (p ¼ 0.213). These results suggest a heritable contribution to all of the histologic subgroups except SCLCs, which might be expected because this is the subtype that is most often associated with tobacco. It was also the subgroup with the highest rate of tobacco contributing to death.
Test for Excess Relatedness (Controlled for Smoking)
Evidence for excess relatedness within histologic subtypes was also investigated according to tobacco use. The results for the test of excess relatedness by histologic subtype are shown in Table 4 for the subsets of individuals with each histologic type who were smokers, nonsmokers, or coded as having unknown tobacco use status.
Excess relatedness was seen when all relationships were considered regardless of smoking status for all histologic subtypes except SCLC and squamous cell carcinoma in nonsmokers. Significant excess distant relatedness was observed for all lung cancer cases, regardless of histologic subgroup, for both smokers (dGIF p ¼ 0.027) and nonsmokers (dGIF p ¼ 0.005).
However, when each histologic subgroup was stratified into smokers or nonsmokers, none of the smoking subgroups showed significant evidence for excess distant relatedness. In contrast, only the nonsmoking 
High-risk Pedigrees
Analysis of the genetic relationships among the 561 nonsmokers with nonsquamous NSCLC identified 61 pedigrees with a significant excess of nonsquamous NSCLC in a nonsmoker (p < 0.05), with each including at least two cases of nonsquamous NSCLC in a nonsmoker. These 61 pedigrees included a total of 157 cases of nonsquamous NSCLC in a nonsmoker.
An example high-risk pedigree of nonsquamous NSCLC in a nonsmoker is shown in Figure 2 . The pedigree founder was born in the early 1800s and has approximately 5000 descendants in the UPDB. This pedigree includes six cases of individuals with nonsquamous NSCLC whose DC indicated that tobacco did not contribute to death, four cases of individuals with nonsquamous NSCLC cases whose DC indicated a contribution of tobacco to death, and three cases of individuals whose DC was not coded for tobacco use. There was a threefold excess of nonsquamous NSCLC observed in the pedigree ( , and lung cancer is the only one of the cancers of 36 sites investigated that was observed in significant excess (21 total observed lung cancers versus 9.9 expected [p ¼ 0.001] with three of these cancers being SCLCs). When these data are taken together, the predisposition of nonsmokers with this pedigree toward development of nonsquamous lung cancer, which is a relatively uncommon cancer, in the setting of low risk for other cancers (low environmental risk or behaviors) supports the probability of finding a causative gene defect in this population. In addition, sex appears to be a characteristic that may define this population. It is noted that five of the six nonsmokers with nonsquamous lung cancer in this example high-risk pedigree (83%) are females. Of the 157 nonsmokers with nonsquamous cell lung cancers who are members of the 61 high-risk pedigrees, 60% are females. Overall, of the 3749 deceased Utahns with lung cancer with genealogy data, only 32% were female. On the other hand, age may not be a characteristic that defines this population. The mean age of death due to nonsquamous lung cancer among the 157 nonsmokers who died of nonsquamous cell lung cancer and were members of the 61 high-risk pedigrees was 68 years, which is essentially the same as the average age at diagnosis (66 years) of all of the individuals with lung cancer with genealogy in the UPDB.
Discussion
Previously, we have shown evidence for a genetic contribution to lung cancer in nonsmokers, and we have further advanced these findings by dissecting the genetic contribution to lung cancer in nonsmokers by histologic subtype. In particular, our findings support a genetic contribution to nonsquamous NSCLC in never-smokers, which is a well-described clinical syndrome. 4 The role of smoking in the development of lung cancer is irrefutable. The exact role and contribution of radon, genetics, and non-smoking-related environmental exposures are still being recognized and evaluated for their impact on the development of lung cancer. 5, [23] [24] [25] [26] Lung cancer is a heterogeneous disease with multiple different histologic subtypes; whether they are induced by similar exposures is of interest. 27 The genetic contribution to different histologic subtypes is unknown. The confounding of shared genetics with shared environmental exposure (e.g., smoking, occupation, childhood environment) makes separation of the genetic contribution to the individual histologic subtypes of lung cancer challenging.
This analysis of familial clustering of lung cancer by histologic subtype and tobacco use is based on analysis of a unique population-based resource representing the population of Utah. This population is recognized for the lowest rate of smoking in the nation, which perhaps enriches analysis of the heritable contribution to lung cancer by reducing noise from the confounding effect on risk of smoking, which may also cluster in pedigrees. A study by Sellers et al. suggested familial clustering of lung cancers across all histologic subtypes with other cancers in a set of 300 patients; however, it did not control for smoking. 6 Two similar studies from Japan examined the association between family history and histologic subtype of lung cancer. Nitadori et al. 7 demonstrated an association between acinar subtype NSCLC and family history with an increased risk for the development of squamous cell carcinoma (hazard ratio ¼ 2.79; 95% confidence interval [CI]: 1.37-5.68) in first-degree relatives and neversmokers (hazard ratio ¼ 2.48; 95% CI: 1.27-4.84). In another study over 28 years in a single institution, 8 125 patients with lung cancer who had at least one first-or second-degree relative with lung cancer were retrospectively examined; adenocarcinoma was most commonly associated with a family history, but again only in close family relationships, and smoking status was not significant.
In a study by Li et al., 9 the genetic contribution to early-onset lung cancer by histologic subtype was examined. Although Li et al. showed an association between different lung cancer histologic subtypes and family history, it was only in first-degree relatives. They did control for smoking, and the RRs for the different histologic subtypes were similar to the overall RR previously published for data on Utah. Two studies examined the risk for the development of lung cancer in never-smokers 28, 29 ; both showed increased risk for lung cancer in individuals with a family history of lung cancer. In both studies, a significant proportion of patients harbored an EGFR mutation, which hints at an inherited predisposition. This observation is consistent with our findings that cases nonsquamous of NSCLC show the strongest evidence for a genetic component. Although we did not perform mutation analysis for this current study (it predates routine molecular testing), this is an area that deserves further focus.
Shared environmental exposure, specifically tobacco smoke, has previously been associated with lung cancer. 30 In a meta-analysis an odds ratio of 1.26 (95% CI: 1.07-1.47) for lung cancer was observed in nonsmoking spouses of smokers, and a linear relationship between lung cancer risk and both the quantity and duration of exposure of smoking by the partner was observed. 31 We previously demonstrated that the RR for lung cancer in the spouses of individuals with smoking-related lung cancer (RR ¼ 2.75, 95% CI: 1.66-4.30) is similar to the RR of smoking-related lung cancer in the first-degree relatives of individuals with smoking-related lung cancer (RR ¼ 2.58, 95% CI: 2.13-3.10), suggesting that genetic risk factor(s) may be equivalent in strength to smoking as a risk factor. 5 The observation of an apparent excess of lung cancer cases in female nonsmokers with high-risk pedigrees is noteworthy, but there is little in the literature on this specific topic. Lin et al. found that female first-degree relatives of individuals with lung cancer tended to have higher risk for lung cancer than male first-degree relatives. 28 Typically studies of lung cancer risk in individuals with a family history that include consideration of sex have noted equivalent patterns in male and female probands. 32 This analysis may have some limitations. These include data censoring, quality of the data on tobacco use, and lack of data for other known environmental risk factors such as secondhand smoke or occupation. Some lung cancer cases lacked tobacco use data and could not be included in our analysis; how this might have influenced our results is unclear. Additionally, to have consistent data on relatives, only cases with deep ancestral genealogy data were included. Relatives of the individuals in the Utah cases whose lung cancer was diagnosed outside Utah or before 1966 were censored, as were cancer cases with no record link to genealogy data. Only cases of lung cancer in deceased individuals who died in Utah and for whom tobacco contribution questions were completed on the DC could be included. It must be noted that the rates of record linking are higher for males than for females because of name changes associated with marriage.
Data on tobacco use were not available for cases in which the individual with lung cancer was still alive, for cases in which the individual died before 1989 or outside Utah, and for cases in which the attending physician at death did not complete tobacco-related questions. Although the DC has separate codes for the contribution of tobacco to the final cause of death, it relies on the physician to accurately provide these data; the accuracy of data tobacco use recorded on DCs has yet to be reported in the literature. Smokers may have been more likely than nonsmokers to have tobacco use coded on their DCs because the smoking phenotype can be determined more easily than the nonsmoking phenotype can. This may explain the high rate of smokers across all histologic subtypes of lung cancer in a state in which smoking rates are reported to remain less than 10%. These limitations apply to the entire UPDB, including cases and controls; they are assumed to be uniform and not associated with bias that would affect the hypothesis tests performed, but they may reduce the power of these analyses. This is the first time that significant excess relatedness has been shown for histologic subtypes of lung cancer, specifically, nonsquamous NSCLC in nonsmokers. Such data may be useful in discussion with patients and family members, as it relates to both screening and risk assessment of newly found pulmonary nodules on the basis of histologic subtype of lung cancers diagnosed in relatives. It may also aid in focusing future endeavors in the search for genes associated with predisposition to lung cancer.
